Bioprinted Skin Recapitulates Normal Collagen Remodeling in Full-Thickness Wounds.
animal models
bioprinting
extracellular matrix
skin
tissue engineering
wound healing
Journal
Tissue engineering. Part A
ISSN: 1937-335X
Titre abrégé: Tissue Eng Part A
Pays: United States
ID NLM: 101466659
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
pubmed:
22
12
2019
medline:
29
5
2021
entrez:
22
12
2019
Statut:
ppublish
Résumé
Over 1 million burn injuries are treated annually in the United States, and current tissue engineered skin fails to meet the need for full-thickness replacement. Bioprinting technology has allowed fabrication of full-thickness skin and has demonstrated the ability to close full-thickness wounds. However, analysis of collagen remodeling in wounds treated with bioprinted skin has not been reported. The purpose of this study is to demonstrate the utility of bioprinted skin for epidermal barrier formation and normal collagen remodeling in full-thickness wounds. Human keratinocytes, melanocytes, fibroblasts, dermal microvascular endothelial cells, follicle dermal papilla cells, and adipocytes were suspended in fibrinogen bioink and bioprinted to form a tri-layer skin structure. Bioprinted skin was implanted onto 2.5 × 2.5 cm full-thickness excisional wounds on athymic mice, compared with wounds treated with hydrogel only or untreated wounds. Total wound closure, epithelialization, and contraction were quantified, and skin samples were harvested at 21 days for histology. Picrosirius red staining was used to quantify collagen fiber orientation, length, and width. Immunohistochemical (IHC) staining was performed to confirm epidermal barrier formation, dermal maturation, vascularity, and human cell integration. All bioprinted skin treated wounds closed by day 21, compared with open control wounds. Wound closure in bioprinted skin treated wounds was primarily due to epithelialization. In contrast, control hydrogel and untreated groups had sparse wound coverage and incomplete closure driven primarily by contraction. Picrosirius red staining confirmed a normal basket weave collagen organization in bioprinted skin-treated wounds compared with parallel collagen fibers in hydrogel only and untreated wounds. IHC staining at day 21 demonstrated the presence of human cells in the regenerated dermis, the formation of a stratified epidermis, dermal maturation, and blood vessel formation in bioprinted skin, none of which was present in control hydrogel treated wounds. Bioprinted skin accelerated full-thickness wound closure by promoting epidermal barrier formation, without increasing contraction. This healing process is associated with human cells from the bioprinted skin laying down a healthy, basket-weave collagen network. The remodeled skin is phenotypically similar to human skin and composed of a composite of graft and infiltrating host cells. Impact statement We have demonstrated the ability of bioprinted skin to enhance closure of full-thickness wounds through epithelialization and normal collagen remodeling. To our knowledge, this article is the first to quantify collagen remodeling by bioprinted skin in full-thickness wounds. Our methods and results can be used to guide further investigation of collagen remodeling by tissue engineered skin products to improve ongoing and future bioprinting skin studies. Ultimately, our skin bioprinting technology could translate into a new treatment for full-thickness wounds in human patients with the ability to recapitulate normal collagen remodeling in full-thickness wounds.
Identifiants
pubmed: 31861970
doi: 10.1089/ten.TEA.2019.0319
pmc: PMC7249461
doi:
Substances chimiques
Collagen
9007-34-5
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
512-526Subventions
Organisme : NIAMS NIH HHS
ID : F30 AR074866
Pays : United States
Références
Nat Commun. 2018 Dec 13;9(1):5301
pubmed: 30546011
Wound Repair Regen. 2009 May-Jun;17(3):318-25
pubmed: 19660039
Nat Biotechnol. 2016 Mar;34(3):312-9
pubmed: 26878319
World J Surg. 1992 Jan-Feb;16(1):87-96
pubmed: 1290271
Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19679-88
pubmed: 24145441
Tissue Eng Part C Methods. 2014 Jun;20(6):473-84
pubmed: 24188635
J Burn Care Res. 2013 Nov-Dec;34(6):612-20
pubmed: 23877140
Stem Cells Transl Med. 2012 Nov;1(11):792-802
pubmed: 23197691
J Pediatr Surg. 2011 Sep;46(9):1759-63
pubmed: 21929986
J Trauma. 2006 Apr;60(4):821-9
pubmed: 16612303
Curr Protoc Cell Biol. 2001 May;Chapter 2:Unit 2.1
pubmed: 18228346
Burns. 2011 Dec;37(8):1343-8
pubmed: 21852044
Biomacromolecules. 2011 Feb 14;12(2):306-13
pubmed: 21182236
Plast Reconstr Surg. 2015 Dec;136(6):1379-88
pubmed: 26595026
Methods Mol Biol. 2012;806:203-14
pubmed: 22057454
Biotechnol Bioeng. 2012 Jul;109(7):1855-63
pubmed: 22328297
Nature. 2007 Feb 22;445(7130):874-80
pubmed: 17314974
Int J Biochem Cell Biol. 2004 Jun;36(6):1031-7
pubmed: 15094118
Tissue Eng Part A. 2017 Oct;23(19-20):1026-1041
pubmed: 28922975
Ann Surg. 1975 Sep;182(3):183-97
pubmed: 809014
Curr Protoc Cell Biol. 2004 Feb;Chapter 2:Unit 2.6
pubmed: 18228450
Am J Pathol. 1994 Jul;145(1):105-13
pubmed: 8030742
Sci Rep. 2019 Feb 12;9(1):1856
pubmed: 30755653
FASEB J. 2007 Oct;21(12):3250-61
pubmed: 17504973
Science. 2014 Nov 21;346(6212):941-5
pubmed: 25414301
Int J Immunopharmacol. 1992 Aug;14(6):963-9
pubmed: 1428369
Biomaterials. 2009 Mar;30(8):1587-95
pubmed: 19108884
PLoS One. 2013;8(3):e57741
pubmed: 23469227
Eplasty. 2009;9:e4
pubmed: 19212431
J Biomed Opt. 2014 Jan;19(1):16007
pubmed: 24407500
Burns. 2011 Nov;37(7):1087-100
pubmed: 21802856
J Biomech. 2010 Jan 5;43(1):55-62
pubmed: 19800626
Int Wound J. 2016 Sep;13 Suppl 3:52-6
pubmed: 27547964
Plast Reconstr Surg. 2015 Oct;136(4):524e-30e
pubmed: 26397272
J Am Acad Dermatol. 2006 Sep;55(3):490-500
pubmed: 16908356